Printer Friendly
The Free Library
5,071,953 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Unigen Issued New Patent on Novel Ingredient.


PhytoLogix Discovery Platform Continues to be Validated by New Science

LACEY, Wash. -- Unigen Pharmaceuticals, Inc., a leading research and development company of proprietary, biologically active plant-derived ingredients has received notification of approval of a USA patent for Free-B-Ring Flavonoids flavonoids,
n.pl common plant pigment compounds that act as antioxidants, enhance the effects of vitamin C, and strengthen connective tissue around capillaries.
 derived from Chinese Skullcap skull·cap
n.
See calvaria.


skullcap,
n Latin names:
Scutellaria laterifolia, Scutellaria baicalensis;
 in supporting its novel Univestin joint health ingredient. This patent brings to 151 the number of US and international patents globally awarded or pending for Unigen.

"Unigen's PhytoLogix discovery platform has yielded many proprietary bioactive bi·o·ac·tive
adj.
Of or relating to a substance that has an effect on living tissue.



bioactive

having an effect on or eliciting a response from living tissue.
 natural products," said Qi Jia, PhD, lead inventor and Chief Science Officer for Unigen Pharmaceuticals. "The previously issued patent on flavans from Acacia species (Patent Number US 7,108,868 B2) and this recently allowed patent on Free-B-Ring flavonoids demonstrates the capability of Unigen's science program to discover the novel usage of flavonoids in supporting joint health."

Univestin is a proprietary blend of two individual ingredients - flavans extracted from Acacia catechu Acacia catechu (ä·kä·sē  and free-b-ring flavonoids from Scutellaria baicalensis Scutellaria baicalensis,
n See skullcap.
. The newly allowed Free-B-Ring flavonoid USA patent will cover this class of natural products from all potential genus and parts of high plants that include Scutellaria genera for treating osteoarthritis osteoarthritis
 or osteoarthrosis or degenerative joint disease

Most common joint disorder, afflicting over 80% of those who reach age 70. It does not involve excessive inflammation and may have no symptoms, especially at first.
; securing final protection of the individual Univestin components.

Among the patent's specifically allowable claims is a "method for treating osteoarthritis...[with] an effective amount of a composition comprising a Free-B-Ring flavonoid or a composition containing a mixture of Free-B-Ring flavonoids and a pharmaceutically acceptable carrier" through "oral, topical, suppository suppository /sup·pos·i·to·ry/ (su-poz´i-tor?e) an easily fusible medicated mass to be introduced into a body orifice, as the rectum, urethra, or vagina.

sup·pos·i·to·ry
n.
, intravenous, and intradermic, intragaster, intramusclar, intraperitoneal and intravenous administration."

About Unigen Pharmaceuticals, Inc.

Unigen Pharmaceuticals, Inc. (www.unigenpharma.com ) is a leading natural products research and development company and proprietary ingredients supplier. The company is dedicated to the discovery of botanically derived therapeutic compounds that address consumer health needs and help improve the quality of human life. Its research and discovery process includes extensive work at both the human cell and gene level. Unigen focuses on identifying and studying the unique ingredients of medicinal botanicals and then formulating proprietary raw materials for use in cosmeceutical cos·me·ceu·ti·cal
n.
A cosmetic that has or is purported to have medicinal properties.
, nutraceutical, functional food and pharmaceutical products. Unigen is part of the ECONET global family of health and natural product companies which have operations in the United States, Canada, Korea, Mexico, Russia and China.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 16, 2007
Words:362
Previous Article:TCW Announces Conference Call with Morningstar Manager of the Year Jeffrey Gundlach.
Next Article:Fitch Takes Rating Actions on 38 Equipment Leasing ABS Transactions.



Related Articles
Evaluating truck tire patents.
Patent News.(multiple companies)
Patent news.(patents details by product, inventor and firm assigned to)
What can be patented? It's a question of novelty: copies of patents referenced here are available from the Patent and Trademark Office, Box 9,...
Here's a recipe for stretch-hood film.(Extrusion)
UNIGEN/UNIV. OF PANAMA SIGN PLANT COLLECTION PACT.
UNIGEN/INCA HEALTH TO DEVELOP PLANT-DERIVED HEALTH PRODUCTS.
Bayer CropScience LP and International Specialty Products Inc. (ISP) sign an agreement through which Bayer CropScience will gain the exclusive rights...
Antimicrobial polymers.(Suppliers Showcase: Materials)
Antimicrobials.(Materials)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles